Key Metrics
CiteScore 

5.9
Impact Factor 

< 5
SJR 

Q1Oncology

SNIP 

1.51
Recommended pre-submission checks
Powered by 

Topics Covered on Breast Cancer: Targets and Therapy
Breast Cancer: Targets and Therapy Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2836 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Breast Cancer: Targets and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Breast Cancer: Targets and Therapy
Discrimination of Triple-Negative Breast Cancer: A Robust Clinical Baseline versus Multimodal Magnetic Resonance Imaging Integrated Models with Assessment of Generalizability
- 2 Apr 2026
- Breast Cancer : Targets and Therapy
Lipid Metabolism and Breast Cancer Therapy: An Integrative Literature Review
- 1 Apr 2026
- Breast Cancer : Targets and Therapy
Prognostic Value of Ki-67 and Progesterone Receptor for Risk Stratification and Outcomes by Adjuvant Chemotherapy in Early Luminal-Type Breast Cancer
- 1 Apr 2026
- Breast Cancer : Targets and Therapy
Novel Insights into the Oncogenic Role and Clinical Significance of ORC6L in Breast Cancer.
- 1 Apr 2026
- Breast cancer (Dove Medical Press)
Single-Cell Profiling Reveals a Treg-Rich, NK Cell-Depleted Immune Microenvironment in Triple-Negative Breast Cancer with High-Glucocorticoid Receptor Expression.
- 1 Apr 2026
- Breast cancer (Dove Medical Press)
Adjuvant Weekly Paclitaxel and Trastuzumab for HER2-Positive Early-Stage Breast Cancer with Preserved Baseline LVEF: Incidence of Cardiotoxicity and Feasibility of Simplified Cardiac Surveillance.
- 1 Apr 2026
- Breast cancer (Dove Medical Press)
Discrimination of Triple-Negative Breast Cancer: A Robust Clinical Baseline versus Multimodal Magnetic Resonance Imaging Integrated Models with Assessment of Generalizability
- 2 Apr 2026
- Breast Cancer : Targets and Therapy
Lipid Metabolism and Breast Cancer Therapy: An Integrative Literature Review
- 1 Apr 2026
- Breast Cancer : Targets and Therapy
Prognostic Value of Ki-67 and Progesterone Receptor for Risk Stratification and Outcomes by Adjuvant Chemotherapy in Early Luminal-Type Breast Cancer
- 1 Apr 2026
- Breast Cancer : Targets and Therapy
Novel Insights into the Oncogenic Role and Clinical Significance of ORC6L in Breast Cancer.
- 1 Apr 2026
- Breast cancer (Dove Medical Press)
Single-Cell Profiling Reveals a Treg-Rich, NK Cell-Depleted Immune Microenvironment in Triple-Negative Breast Cancer with High-Glucocorticoid Receptor Expression.
- 1 Apr 2026
- Breast cancer (Dove Medical Press)
Adjuvant Weekly Paclitaxel and Trastuzumab for HER2-Positive Early-Stage Breast Cancer with Preserved Baseline LVEF: Incidence of Cardiotoxicity and Feasibility of Simplified Cardiac Surveillance.
- 1 Apr 2026
- Breast cancer (Dove Medical Press)